The health ministry has ordered AstraZeneca K.K., the importer of the controversial lung cancer drug Iressa, to include a patient form with the medicine clearly stating the possibility of fatal side effects, ministry sources said Tuesday.

It is the first time the ministry has ordered a drug firm to make explicit the possibility that a drug may have life-threatening effects in a patient form.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.